ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

Abstracts From AACR Annual Meeting

May 21, 1976

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists

June 7, 1974

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983